According to Dr. Decker, LGV is another uncommon STD. It is caused by 3 unique strains (serovars L1, L2, or L3) of Chlamydia trachomatis
. Among heterosexual individuals. LGV typically manifests as a genital lesion, such as an ulcer or papule, and regional inguinal and/or femoral lymphadenopathy. However, in MSM, it may manifest as severe proctocolitis that can resemble inflammatory bowel disease. Symptoms in MSM include bloody rectal discharge, and may be associated with tenesmus, colorectal strictures or fistulas, and pain.
Although diagnosis of LGV is based predominantly on clinical findings, NAAT on specimens from the affected area (rectal or lesion swabs) is preferred for confirmation. Individuals in whom LGV is suspected should be presumptively treated for the disease—usually with a doxycycline-based regimen. Suspected cases of LGV should also be reported to the state health department. Sexual partners of infected individuals should also be examined, tested, and treated for LGV if they engaged in sexual contact with the individual within 2 months before the onset of symptoms.
is also an emerging cause of sexually transmitted infections in men and women. It is recognized as an important cause of about 25% of cases of non-gonococcal urethritis in men. M. genitalium
is also associated with cervicitis, pelvic inflammatory disease (PID), infertility, and preterm delivery in women; infections in women are also often asymptomatic.
Diagnosis of M. genitalium
is also based mainly on clinical findings. Because culture of M. genitalium
can take up to 6 months, NAAT (on urine samples, or urethral, vaginal, and cervical swabs) is preferred for confirmation of infection. However, NAAT for this organism is not yet widely available. As a consequence, treatment of M. genitalium
infection typically occurs in a syndrome-based approach to the management of the patient’s symptoms.
For urethritis, azithromycin has been shown to be more effective than doxycycline, although resistance to azithromycin is rapidly emerging. Dr. Decker also notes that “[r]ecommended PID treatment regimens are based on antibiotics that are not effective against M. genitalium
. Therefore, clinicians might consider M. genitalium
in cases that do not respond to therapy within 7 to 10 days.” Moxifloxacin has been successfully used to treat M. genitalium
in men and women with previous treatment failures—in particular in those who experience persistent symptoms and in whom infection is confirmed, concludes Dr. Decker.
Dr. Parry graduated from the University of Liverpool, England in 1997 and is a board-certified veterinary pathologist. After 13 years working in academia, she founded Midwest Veterinary Pathology, LLC where she now works as a private consultant. She is passionate about veterinary education and serves on the Indiana Veterinary Medical Association’s Continuing Education Committee. She regularly writes continuing education articles for veterinary organizations and journals, and has also served on the American College of Veterinary Pathologists’ Examination Committee and Education Committee.
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.